Utility Study in Diffuse Large B-Cell Lymphoma (DLBCL)

CompletedOBSERVATIONAL
Enrollment

91

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Diffuse Large B-Cell Lymphoma
Trial Locations (1)

SL7 2FF

PH Associates - an OPen Health Company, Marlow

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02708732 - Utility Study in Diffuse Large B-Cell Lymphoma (DLBCL) | Biotech Hunter | Biotech Hunter